TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Low Molecular Weight Heparin on Survival of Stage I,II or IIIA Non Small Cell Lung Cancer. A Multicenter, Open, Randomized Controlled Trial.
Brief Summary: Experiments suggest that low molecular weight heparin (LMWH) inhibits tumor growth and metastasis. Studies in humans suggest that LMWH is associated with a higher survival in patients with cancer related thrombosis. Two recent studies suggest that LMWH may increase the survival of patients with cancer who do not have an associated thrombosis. The purpose of the study is to assess the effect of LMWH on the overall survival of patients with localized non-small cell lung cancer after complete surgical resection.


Options:
A: Arm Label: Semuloparin; Type: EXPERIMENTAL; Interventions: Drug: Semuloparin sodium | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (for semuloparin) | Intervention Type: DRUG; Name: Semuloparin sodium; Assigned to Arm(s): Semuloparin | Intervention Type: DRUG; Name: Placebo (for semuloparin); Assigned to Arm(s): Placebo
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tinzaparin sodium 100 UI/Kg/OD for 12 weeks | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: Tinzaparin sodium 100 UI/Kg/OD for 12 weeks | Intervention Type: DRUG; Name: Tinzaparin sodium 100 UI/Kg/OD for 12 weeks; Assigned to Arm(s): A, B
C: Arm Label: A; Type: OTHER; Interventions: Drug: cisplatinum or carboplatin and e.g.etoposide. | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: cisplatinum or carboplatin and e.g.etoposide+enoxaparin | Intervention Type: DRUG; Name: cisplatinum or carboplatin and e.g.etoposide.; Assigned to Arm(s): A | Intervention Type: DRUG; Name: cisplatinum or carboplatin and e.g.etoposide+enoxaparin; Assigned to Arm(s): B
D: Arm Label: Arm A; Type: ACTIVE_COMPARATOR; Interventions: Drug: cisplatin + docetaxel | Arm Label: Arm B; Type: EXPERIMENTAL; Interventions: Drug: cisplatin + docetaxel + enoxaparin | Intervention Type: DRUG; Name: cisplatin + docetaxel; Assigned to Arm(s): Arm A | Intervention Type: DRUG; Name: cisplatin + docetaxel + enoxaparin; Assigned to Arm(s): Arm B

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stress and Adaptation in Rheumatoid Arthritis (SARA)
Brief Summary: Rheumatoid arthritis (RA) is an autoimmune disease that causes long-term inflammation of the joints and occasionally, other body tissues. The purpose of this study is to evaluate two different types of cognitive behavioral therapy (CBT) in reducing RA disease activity and improving mental health of adults with RA.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavior Therapy for Pain (CBT-P) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness Meditation for Emotion Regulation (MM-ER) | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Rheumatoid arthritis education | Intervention Type: BEHAVIORAL; Name: Cognitive Behavior Therapy for Pain (CBT-P); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Mindfulness Meditation for Emotion Regulation (MM-ER); Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Rheumatoid arthritis education; Assigned to Arm(s): 3
B: Intervention Type: BEHAVIORAL; Name: self-management program; Assigned to Arm(s): N/A
C: Intervention Type: PROCEDURE; Name: Mod. functional restoration-Individ. dynamic back-muscle; Assigned to Arm(s): N/A
D: Arm Label: Standard; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard physical therapy | Arm Label: Graded exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Graded exercise | Arm Label: Graded exposure; Type: EXPERIMENTAL; Interventions: Other: Graded exposure | Intervention Type: BEHAVIORAL; Name: Standard physical therapy; Assigned to Arm(s): Standard | Intervention Type: BEHAVIORAL; Name: Graded exercise; Assigned to Arm(s): Graded exercise | Intervention Type: OTHER; Name: Graded exposure; Assigned to Arm(s): Graded exposure

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stress and Adaptation in Rheumatoid Arthritis (SARA)
Brief Summary: Rheumatoid arthritis (RA) is an autoimmune disease that causes long-term inflammation of the joints and occasionally, other body tissues. The purpose of this study is to evaluate two different types of cognitive behavioral therapy (CBT) in reducing RA disease activity and improving mental health of adults with RA.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavior Therapy for Pain (CBT-P) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness Meditation for Emotion Regulation (MM-ER) | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Rheumatoid arthritis education | Intervention Type: BEHAVIORAL; Name: Cognitive Behavior Therapy for Pain (CBT-P); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Mindfulness Meditation for Emotion Regulation (MM-ER); Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Rheumatoid arthritis education; Assigned to Arm(s): 3
B: Intervention Type: BEHAVIORAL; Name: cognitive-behavioral therapy; Assigned to Arm(s): N/A
C: Arm Label: Back school; Type: EXPERIMENTAL; Interventions: Behavioral: back school | Arm Label: back school; Type: EXPERIMENTAL; Interventions: Behavioral: back school | Intervention Type: BEHAVIORAL; Name: back school; Assigned to Arm(s): Back school, back school
D: Arm Label: Prescribed physical activity; Type: OTHER; Interventions: Other: Prescribed physical activity | Arm Label: Neck specific training; Type: OTHER; Interventions: Other: Neck specific training | Intervention Type: OTHER; Name: Prescribed physical activity; Assigned to Arm(s): Prescribed physical activity | Intervention Type: OTHER; Name: Neck specific training; Assigned to Arm(s): Neck specific training

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Multicenter, Single Blind, Randomized, Comparative and add-on Clinical Trial, in Three Parallel Groups, to Evaluate Efficacy and Safety of a New Therapy With Adipose-derived Autologous Stem Cells for the Treatment of Complex Perianal Fistulas in Patients Without Inflammatory Bowel Disease
Brief Summary: Anal fistula is defined as an abnormal communication between the anal canal and the perianal skin. Adipose-derived stem cells are a new therapy for the closure of these fistulas. This study will test the safety and efficacy of ASCs (adipose stem cells) in the treatment of patients without Crohn´s disease.


Options:
A: Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Procedure: Localization, curettage of the fistulous tract and closure of the internal opening without MSC injection. | Arm Label: Cohort 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Localization, curettage of the fistulous tract and closure of the internal opening with local MSC injection. | Arm Label: Cohort 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Localization, curettage of the fistulous tract and closure of the internal opening with local MSC injection. | Arm Label: Cohort 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Localization, curettage of the fistulous tract and closure of the internal opening with local MSC injection. | Intervention Type: PROCEDURE; Name: Localization, curettage of the fistulous tract and closure of the internal opening without MSC injection.; Assigned to Arm(s): Control group | Intervention Type: PROCEDURE; Name: Localization, curettage of the fistulous tract and closure of the internal opening with local MSC injection.; Assigned to Arm(s): Cohort 1, Cohort 2, Cohort 3
B: Arm Label: ASCs; Type: EXPERIMENTAL; Interventions: Drug: ASCs (Cx401, company code) | Arm Label: ASCs+fibrin glue; Type: EXPERIMENTAL; Interventions: Drug: ASCs (Cx401, company code), Drug: Fibrin adhesive | Arm Label: Fibrin glue; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fibrin adhesive | Intervention Type: DRUG; Name: ASCs (Cx401, company code); Assigned to Arm(s): ASCs, ASCs+fibrin glue | Intervention Type: DRUG; Name: Fibrin adhesive; Assigned to Arm(s): ASCs+fibrin glue, Fibrin glue
C: Arm Label: Vedolizumab; Type: EXPERIMENTAL; Interventions: Drug: vedolizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: vedolizumab; Assigned to Arm(s): Vedolizumab | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Treatment; Type: OTHER; Interventions: Procedure: Injection with freshly collected autologous adipose tissue | Intervention Type: PROCEDURE; Name: Injection with freshly collected autologous adipose tissue; Assigned to Arm(s): Treatment

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Vaginal Mesh for Prolapse
Brief Summary: The primary aim of this double-blind, randomized clinical trial (RCT) is to test the hypothesis that the addition of a standardized technique of interpositional synthetic polypropylene mesh placement improves the one-year outcome of vaginal reconstructive surgery for pelvic organ prolapse compared to traditional vaginal reconstructive surgery without mesh.


Options:
A: Arm Label: Prolift mesh; Type: ACTIVE_COMPARATOR; Interventions: Device: synthetic monofilament polypropylene mesh | Arm Label: Prolapse repair without mesh; Type: ACTIVE_COMPARATOR; Interventions: Device: synthetic monofilament polypropylene mesh | Intervention Type: DEVICE; Name: synthetic monofilament polypropylene mesh; Assigned to Arm(s): Prolapse repair without mesh, Prolift mesh
B: Arm Label: Interrupted suture; Type: ACTIVE_COMPARATOR; Interventions: Device: Device is the type of suture used: Quill suture vs. Interrupted suture | Arm Label: Quill suture; Type: ACTIVE_COMPARATOR; Interventions: Device: Device is the type of suture used: Quill suture vs. Interrupted suture | Intervention Type: DEVICE; Name: Device is the type of suture used: Quill suture vs. Interrupted suture; Assigned to Arm(s): Interrupted suture, Quill suture
C: Arm Label: SORD-BILL; Type: EXPERIMENTAL; Interventions: Procedure: PKS BILL-PKS PlasmaSORD Versus Conventional surgical techniques | Arm Label: STANDARD; Type: ACTIVE_COMPARATOR; Interventions: Procedure: PKS BILL-PKS PlasmaSORD Versus Conventional surgical techniques | Intervention Type: PROCEDURE; Name: PKS BILL-PKS PlasmaSORD Versus Conventional surgical techniques; Assigned to Arm(s): SORD-BILL, STANDARD
D: Arm Label: Single-port sacrocolpopexy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Single-port sacrocolpopexy | Arm Label: Multi-port sacrocolpopexy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Multi-port sacrocolpopexy | Intervention Type: PROCEDURE; Name: Single-port sacrocolpopexy; Assigned to Arm(s): Single-port sacrocolpopexy | Intervention Type: PROCEDURE; Name: Multi-port sacrocolpopexy; Assigned to Arm(s): Multi-port sacrocolpopexy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Vaginal Mesh for Prolapse
Brief Summary: The primary aim of this double-blind, randomized clinical trial (RCT) is to test the hypothesis that the addition of a standardized technique of interpositional synthetic polypropylene mesh placement improves the one-year outcome of vaginal reconstructive surgery for pelvic organ prolapse compared to traditional vaginal reconstructive surgery without mesh.


Options:
A: Arm Label: SIS Mesh (Cook Medical); Type: EXPERIMENTAL; Interventions: Device: SIS mesh (Cook Medical), Procedure: Anterior prolapse repair | Arm Label: No-mesh; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Anterior prolapse repair | Intervention Type: DEVICE; Name: SIS mesh (Cook Medical); Assigned to Arm(s): SIS Mesh (Cook Medical) | Intervention Type: PROCEDURE; Name: Anterior prolapse repair; Assigned to Arm(s): No-mesh, SIS Mesh (Cook Medical)
B: Intervention Type: DEVICE; Name: Low-weight prolypropylene mesh; Assigned to Arm(s): N/A
C: Arm Label: Prolift mesh; Type: ACTIVE_COMPARATOR; Interventions: Device: synthetic monofilament polypropylene mesh | Arm Label: Prolapse repair without mesh; Type: ACTIVE_COMPARATOR; Interventions: Device: synthetic monofilament polypropylene mesh | Intervention Type: DEVICE; Name: synthetic monofilament polypropylene mesh; Assigned to Arm(s): Prolapse repair without mesh, Prolift mesh
D: Arm Label: Mesh surgery; Type: EXPERIMENTAL; Interventions: Device: Tensionfree vaginal mesh kit (Prolift) | Arm Label: Conventional vaginal surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: classic vaginal prolapse surgery (fascia plication) | Intervention Type: DEVICE; Name: Tensionfree vaginal mesh kit (Prolift); Assigned to Arm(s): Mesh surgery | Intervention Type: PROCEDURE; Name: classic vaginal prolapse surgery (fascia plication); Assigned to Arm(s): Conventional vaginal surgery

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Vaginal Mesh for Prolapse
Brief Summary: The primary aim of this double-blind, randomized clinical trial (RCT) is to test the hypothesis that the addition of a standardized technique of interpositional synthetic polypropylene mesh placement improves the one-year outcome of vaginal reconstructive surgery for pelvic organ prolapse compared to traditional vaginal reconstructive surgery without mesh.


Options:
A: Arm Label: Polypropylene Mesh; Type: ACTIVE_COMPARATOR; Interventions: Device: Polypropylene mesh (Polyform by Boston Scientific) | Arm Label: Anterior Colporrhaphy; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Anterior Colporrhaphy | Arm Label: Porcine Dermis; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Porcine Dermis (Pelvicol by CRBard) | Intervention Type: DEVICE; Name: Polypropylene mesh (Polyform by Boston Scientific); Assigned to Arm(s): Polypropylene Mesh | Intervention Type: PROCEDURE; Name: Porcine Dermis (Pelvicol by CRBard); Assigned to Arm(s): Porcine Dermis | Intervention Type: PROCEDURE; Name: Anterior Colporrhaphy; Assigned to Arm(s): Anterior Colporrhaphy
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Anterior colporrhaphy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Anterior PROLIFT | Intervention Type: PROCEDURE; Name: Anterior colporrhaphy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Anterior PROLIFT; Assigned to Arm(s): 2
C: Arm Label: Prolift mesh; Type: ACTIVE_COMPARATOR; Interventions: Device: synthetic monofilament polypropylene mesh | Arm Label: Prolapse repair without mesh; Type: ACTIVE_COMPARATOR; Interventions: Device: synthetic monofilament polypropylene mesh | Intervention Type: DEVICE; Name: synthetic monofilament polypropylene mesh; Assigned to Arm(s): Prolapse repair without mesh, Prolift mesh
D: Arm Label: Abdominal Sacral Colpopexy with no Burch colposuspension; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Abdominal Sacral Colpopexy with Burch Colposuspension; Type: EXPERIMENTAL; Interventions: Procedure: Burch urethropexy at time of sacrocolpopexy | Intervention Type: PROCEDURE; Name: Burch urethropexy at time of sacrocolpopexy; Assigned to Arm(s): Abdominal Sacral Colpopexy with Burch Colposuspension

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Vaginal Mesh for Prolapse
Brief Summary: The primary aim of this double-blind, randomized clinical trial (RCT) is to test the hypothesis that the addition of a standardized technique of interpositional synthetic polypropylene mesh placement improves the one-year outcome of vaginal reconstructive surgery for pelvic organ prolapse compared to traditional vaginal reconstructive surgery without mesh.


Options:
A: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: robotic laparoscopic sacrocolpopexy | Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Laparoscopic Sacral Colpopexy | Intervention Type: PROCEDURE; Name: robotic laparoscopic sacrocolpopexy; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: Laparoscopic Sacral Colpopexy; Assigned to Arm(s): 1
B: Intervention Type: PROCEDURE; Name: sacral colpopexy; Assigned to Arm(s): N/A
C: Arm Label: Prolift mesh; Type: ACTIVE_COMPARATOR; Interventions: Device: synthetic monofilament polypropylene mesh | Arm Label: Prolapse repair without mesh; Type: ACTIVE_COMPARATOR; Interventions: Device: synthetic monofilament polypropylene mesh | Intervention Type: DEVICE; Name: synthetic monofilament polypropylene mesh; Assigned to Arm(s): Prolapse repair without mesh, Prolift mesh
D: Arm Label: SSLF and PMT; Type: EXPERIMENTAL; Interventions: Procedure: SSLF, Behavioral: PMT | Arm Label: ULS and PMT; Type: EXPERIMENTAL; Interventions: Procedure: ULS, Behavioral: PMT | Arm Label: SSLF without PMT; Type: EXPERIMENTAL; Interventions: Procedure: SSLF | Arm Label: ULS without PMT; Type: EXPERIMENTAL; Interventions: Procedure: ULS | Intervention Type: PROCEDURE; Name: SSLF; Assigned to Arm(s): SSLF and PMT, SSLF without PMT | Intervention Type: PROCEDURE; Name: ULS; Assigned to Arm(s): ULS and PMT, ULS without PMT | Intervention Type: BEHAVIORAL; Name: PMT; Assigned to Arm(s): SSLF and PMT, ULS and PMT

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Brief Summary: This is an observational study to assess the long-term safety of Protopic® Ointment for the treatment of atopic dermatitis. Patients whose ages are/were \< 16 years at the time of first tacrolimus ointment exposure are eligible to participate. No drug is distributed during this observational trial.


Options:
A: Arm Label: AN2898 ointment, 1%, vs. ointment vehicle; Type: EXPERIMENTAL; Interventions: Drug: AN2898 ointment, 1%, Drug: AN2898 ointment vehicle | Arm Label: AN2728 ointment, 2%, vs. ointment vehicle; Type: EXPERIMENTAL; Interventions: Drug: AN2728 ointment, 2%, Drug: AN2728 ointment vehicle | Intervention Type: DRUG; Name: AN2728 ointment, 2%; Assigned to Arm(s): AN2728 ointment, 2%, vs. ointment vehicle | Intervention Type: DRUG; Name: AN2898 ointment, 1%; Assigned to Arm(s): AN2898 ointment, 1%, vs. ointment vehicle | Intervention Type: DRUG; Name: AN2898 ointment vehicle; Assigned to Arm(s): AN2898 ointment, 1%, vs. ointment vehicle | Intervention Type: DRUG; Name: AN2728 ointment vehicle; Assigned to Arm(s): AN2728 ointment, 2%, vs. ointment vehicle
B: Arm Label: Arm 1 - Standard of Care; Type: ACTIVE_COMPARATOR; Interventions: Drug: EUCRISA | Arm Label: Arm 2 - Online Treatment Response; Type: EXPERIMENTAL; Interventions: Behavioral: Online Treatment response, Drug: EUCRISA | Intervention Type: BEHAVIORAL; Name: Online Treatment response; Assigned to Arm(s): Arm 2 - Online Treatment Response | Intervention Type: DRUG; Name: EUCRISA; Assigned to Arm(s): Arm 1 - Standard of Care, Arm 2 - Online Treatment Response
C: Arm Label: Crisaborole ointment 2%; Type: EXPERIMENTAL; Interventions: Drug: Crisaborole ointment 2% | Intervention Type: DRUG; Name: Crisaborole ointment 2%; Assigned to Arm(s): Crisaborole ointment 2%
D: Arm Label: 1. Protopic Exposure; Type: N/A; Interventions: N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial of Postplacental or Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device After Vaginal Delivery
Brief Summary: This study is a randomized controlled trial comparing 6 month usage rates of the levonorgestrel-releasing intrauterine device (LNG-IUD) when inserted postplacentally after vaginal delivery or delayed placement at 6-8 weeks postpartum. Given the high rate of unintended pregnancy in the United States, particularly in postpartum women, there is a need for reliable, effective, long-term contraception such as the IUD in postpartum women. Postplacental insertion of intrauterine contraception would help to address this need. The primary hypothesis of this study is that use of the LNG-IUD at 6 months after vaginal delivery will be higher in women who have immediate postplacental insertion as compared to delayed insertion 6-8 weeks following delivery.


Options:
A: Arm Label: early insertion; Type: EXPERIMENTAL; Interventions: Drug: early insertion | Arm Label: conventional insertion; Type: ACTIVE_COMPARATOR; Interventions: Drug: conventional insertion | Intervention Type: DRUG; Name: early insertion; Assigned to Arm(s): early insertion | Intervention Type: DRUG; Name: conventional insertion; Assigned to Arm(s): conventional insertion
B: Arm Label: Levonorgestrel (LNG) implants immediately postpartum; Type: ACTIVE_COMPARATOR; Interventions: Device: Jadelle | Arm Label: Levonorgestrel (LNG) implants 6 weeks postpartum; Type: ACTIVE_COMPARATOR; Interventions: Device: Jadelle | Intervention Type: DEVICE; Name: Jadelle; Assigned to Arm(s): Levonorgestrel (LNG) implants immediately postpartum | Intervention Type: DEVICE; Name: Jadelle; Assigned to Arm(s): Levonorgestrel (LNG) implants 6 weeks postpartum
C: Arm Label: Postplacental IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Arm Label: Delayed IUD insertion; Type: ACTIVE_COMPARATOR; Interventions: Device: Levonorgestrel-releasing IUD (Mirena) | Intervention Type: DEVICE; Name: Levonorgestrel-releasing IUD (Mirena); Assigned to Arm(s): Delayed IUD insertion, Postplacental IUD insertion
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Etonogestrel contraceptive implant | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Etonogestrel contraceptive implant | Intervention Type: DRUG; Name: Etonogestrel contraceptive implant; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Etonogestrel contraceptive implant; Assigned to Arm(s): 2

Answer: C